Skip to content
Twitter page opens in new windowLinkedin page opens in new windowInstagram page opens in new window
investorenquiries@pharmaust.com+61 8 9202 6814
PharmAust (PAA)
PharmAust (PAA)
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT
  • HOME
  • ABOUT
    • Company Overview
    • PharmAust Management
    • Board
    • Corporate Directory
  • PIPELINE & TRIALS
    • Therapeutic Pipeline
    • MPL Veterinary Trial Details
    • MPL and Veterinary Trials
    • Veterinary Trial Testimonials
    • MPL and Human Trials
    • Publications
    • Pet Cancer Information Service
    • Motor Neuron Disease Trial
  • INVESTOR CENTRE
    • PhamAust AGM 2022
    • News & Announcements
    • Company Research
    • Financial Reports
    • Annual Reports
    • Investor Presentations
    • Corporate Governance
    • Top 20 Shareholders
  • MEDIA
    • Fireside Chat with Dr Roger Aston
    • Fireside Chat with Dr Kim
    • PharmAust Webinar
    • Epichem Webinar
    • BB PAA Video – September 2021
    • OHD Benchtop Flow Reactor Launch
    • Dr Richard Mollard – Full Interview Ticker TV – 17th June 2020
    • Interview with TechInvest – May 2020
    • Dr. Richard Mollard – 6IX Interview March 2020
    • PharmAust In the News
    • PharmAust Videos
    • PharmAust New Cancer Treatment
    • PharmAust and Catalent Commence GMP Tablet Manufacture (Audio)
    • PharmAust on Youtube
  • CONTACT

Author Archives: PharmAust

Epichem Wins Export Award

News & Announcements 2019By PharmAustOctober 4, 2019

191004_Epichem Wins Export Award

PharmAust Raises $2.4 Million in Placement

News & Announcements 2019By PharmAustOctober 3, 2019

191003_PharmAust Raises $2.4million

October 1, Trading Halt

News & Announcements 2019By PharmAustSeptember 30, 2019

191001_Trading Halt

30 September 2019, Top 20 Shareholders

News & Announcements 2019By PharmAustSeptember 30, 2019

191001_Top Holders September 2019

26 September, Exercise of Options

Financial Reports 2019, News & Announcements 2019By PharmAustSeptember 26, 2019

190926_Exercise of Options

24 September, Notice of Annual General Meeting/ Proxy Form

News & Announcements 2019By PharmAustSeptember 24, 2019

190924_Notice of Annual General Meeting:Proxy Form

2019 Annual Report

Annual Reports 2019By PharmAustSeptember 24, 2019

2019 Annual Report

2018 Annual Report

Annual Reports 2018By PharmAustSeptember 24, 2019

2018 Annual Report

2017 Annual Report

Annual Reports 2017By PharmAustSeptember 24, 2019

2017 Annual Report

2016 Annual Report

Annual Reports 2016By PharmAustSeptember 24, 2019

2016 Annual Report

←1
23456789101112131415
…1617181920…
212223242526272829303132333435363738394041424344454647
48→
MENU
  • Home
  • About Us
  • Pipeline & Trials
  • Investor Centre
  • Media
  • Contact Us
SUBSCRIBE TO OUR NEWSLETTER


Facebook
Facebook
fb-share-icon
Twitter
YouTube
TWITTER

PharmAust Follow

PharmAust is a clinical-stage biotech company developing drug discovery IP to treat cancer, viral and neurological diseases. ASX: $PAA FSE: $ECQ

PharmAust
pharmaust PharmAust @pharmaust ·
15 Mar

Pet care sector’s nothing to sniff at https://www.heraldsun.com.au/business/victoria-business/tim-boreham-australian-pet-care-sector-is-nothing-to-sniff-at/news-story/b508df6b5abc1f1271607dfaf42ccf06 via @theheraldsun

Reply on Twitter 1636148718847299584 Retweet on Twitter 1636148718847299584 2 Like on Twitter 1636148718847299584 8 Twitter 1636148718847299584
Retweet on Twitter PharmAust Retweeted
asxdecks ASX Decks @asxdecks ·
15 Mar

Pharmaust Limited $PAA $PAA.AX

New #ASX investor presentation: PharmAust Investor Webinar Presentation

Questions / feedback for ASX:PAA? Ask at https://tinyurl.com/25vr9ujv?entry.96502678=PAA

Reply on Twitter 1636120690091868161 Retweet on Twitter 1636120690091868161 2 Like on Twitter 1636120690091868161 2 Twitter 1636120690091868161
pharmaust PharmAust @pharmaust ·
15 Mar

🚨 Reminder that $PAA/@PharmAust Executive Chairman, Dr Roger Aston will be presenting TODAY as part of the free @broker_briefing Biotech & Nutrition Investor Webinar

Register here 👇
https://us06web.zoom.us/webinar/register/1716606999117/WN_Hwj9PbRTRE2qtdPZ0rtPSA

Reply on Twitter 1636115496323149824 Retweet on Twitter 1636115496323149824 2 Like on Twitter 1636115496323149824 8 Twitter 1636115496323149824
Load More
Copyright © 2023 PharmAust. All rights reserved.
nil

Website Design & Digital Marketing Perth by Total Click Solutions

Go to Top